Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01357668 · ClinicalTrials.gov registry record

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

A clinical trial of Juvenile Idiopathic Arthritis, sponsored by Bristol-Myers Squibb.

Active
Registry status
800
Enrollment target
20
Study locations

NCT01357668 is a study of Juvenile Idiopathic Arthritis that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 800 participants, above the 203-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (294% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01357668, a study of Juvenile Idiopathic Arthritis, is active but no longer recruiting, sponsored by Bristol-Myers Squibb.

ACTIVE NOT RECRUITING
Registry status
800 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Conditions Studied

Juvenile Idiopathic Arthritis

Study Locations (20)

Other

  • Local Institution - 0025 - Bregenz
  • Local Institution - 0002 - Innsbruck
  • Local Institution - 0032 - Vienna
  • Local Institution - 0027 - Rio de Janeiro
  • Local Institution - 0012 - Copenhagen
  • Local Institution - 0005 - Paris
  • Local Institution - 0041 - Toulouse
  • Local Institution - 0003 - Bad Bramstedt
  • Local Institution - 0030 - Berlin
  • Local Institution - 0034 - Freiburg im Breisgau

São Paulo

  • Local Institution - 0010 - Botucatu
  • Local Institution - 0026 - Campinas
  • Local Institution - 0028 - São Paulo

Arkansas

  • Local Institution - 0060 - Little Rock

New Jersey

  • Local Institution - 0001 - Princeton

Ohio

  • Local Institution - 0059 - Cincinnati

Alberta

  • Local Institution - 0029 - Calgary

Quebec

  • Local Institution - 0011 - Montreal

Central Jutland

  • Local Institution - 0035 - Aarhus

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2013-01-30
Est. Completion 2029-01-02

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01357668

The ClinicalTrials.gov registry entry for NCT01357668 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 203-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (294% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Juvenile Idiopathic Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT01357668 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, São Paulo, Arkansas.

Frequently Asked Questions

What is clinical trial NCT01357668 about?

NCT01357668 is a clinical study titled "An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis". The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

What is the current status of trial NCT01357668?

This trial is currently active not recruiting. The enrollment target is 800 participants. The study started on 2013-01-30. Estimated completion is 2029-01-02.

What conditions does trial NCT01357668 study?

This clinical trial studies the following conditions: Juvenile Idiopathic Arthritis.

Who is sponsoring clinical trial NCT01357668?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01357668 being conducted?

This trial has 20 study locations across Arkansas, New Jersey, Ohio, São Paulo, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Juvenile Idiopathic Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Juvenile Idiopathic Arthritis

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.